Gsa Capital Partners LLP Atossa Therapeutics, Inc. Transaction History
Gsa Capital Partners LLP
- $1.43 Billion
- Q2 2025
A detailed history of Gsa Capital Partners LLP transactions in Atossa Therapeutics, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 51,029 shares of ATOS stock, worth $39,292. This represents 0.0% of its overall portfolio holdings.
Number of Shares
51,029Holding current value
$39,292% of portfolio
0.0%Shares
9 transactions
Others Institutions Holding ATOS
# of Institutions
83Shares Held
24.2MCall Options Held
63.6KPut Options Held
53.2K-
Black Rock Inc. New York, NY9.2MShares$7.08 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.83MShares$4.49 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN2.97MShares$2.29 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.81MShares$1.4 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.3MShares$1 Million0.0% of portfolio
About ATOSSA THERAPEUTICS, INC.
- Ticker ATOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 126,624,000
- Market Cap $97.5M
- Description
- Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...